Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-014787
Filing Date
2015-11-12
Accepted
2015-11-12 17:29:12
Documents
1
Period of Report
2015-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3789
  Complete submission text file 0001179110-15-014787.txt   5155
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORP. 215 FIRST STREET, SUITE 340/350 CAMBRIDGE MA 02142
Business Address
Albers Jeffrey W. (Reporting) CIK: 0001638474 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 151226050